目錄:亞科因(武漢)生物技術(shù)有限公司>>細(xì)胞因子及蛋白>>細(xì)胞因子>> Mouse G-CSF protein重組小鼠粒細(xì)胞集落刺激因子(G-CSF)
產(chǎn)品英文名稱 | Mouse G-CSF protein |
產(chǎn)品中文名稱 | 重組小鼠粒細(xì)胞集落刺激因子(G-CSF) |
別名 | G-CSF; Colony Stimulating Factor 3; Granulocyte; GCSF |
標(biāo)簽 | 無標(biāo)簽 |
表達宿主 | 大腸桿菌 |
種屬 | 小鼠 |
序列 | 氨基酸序列來源于:重組小鼠粒細(xì)胞集落刺激因子(G-CSF) (P09920) (V31-A208) 表達的蛋白片段。 |
活性 | 通過其誘導(dǎo)M-NFS-60細(xì)胞增殖的能力來測定。ED50為2.038 pg/mL。 |
蛋白長度 | 重組小鼠粒細(xì)胞集落刺激因子(G-CSF) 由178個氨基酸組成,預(yù)測分子量為18.95 KD。 |
純度 | > 99% ,使用SDS-PAGE檢測 |
特點&優(yōu)勢 | 通過LAL法測定,每微克蛋白里內(nèi)毒素含量<1.0>1.0> |
產(chǎn)品形式 | 凍干粉,凍干緩沖液為無菌的20 mM Tris,150 mM NaCl,pH 7.4。 |
基因ID | 12985 |
蛋白序列鏈接 | /uniprotkb/P09920/entry |
使用中注意事項 | 開蓋使用前,請先離心。本產(chǎn)品為凍干粉,推薦用該產(chǎn)品配套的Reconstitution Buffer進行復(fù)溶,且濃度不低于100 µg/mL??蛻艨筛鶕?jù)后續(xù)的實驗需求,進行進一步的稀釋。 |
保存建議 | 本產(chǎn)品為凍干粉形式,建議:將凍干粉產(chǎn)品保存于-20℃以下的干燥環(huán)境中。本產(chǎn)品溶解之后,可在4℃保存2-7天,長期使用請置于-20℃以下。為長期保存,推薦添加載體蛋白(0.1% HAS/BSA或12%FBS),并酌情分裝保存,避免反復(fù)凍融。 |
運輸條件 | 冰袋運輸(藍(lán)冰) |
警告 | 本文列出的產(chǎn)品僅供研究使用,不適用于人類或臨床診斷。我們產(chǎn)品所推薦應(yīng)用,不是建議使用我們的產(chǎn)品去違反任何或許可證。對于使用本產(chǎn)品可能發(fā)生的侵權(quán)或其他違規(guī)行為,我們不承擔(dān)任何責(zé)任。 |
背景 | Granulocyte-colony stimulating factor (G-CSF) is a growth factor and an essential cytokine belonging to the CSF family of hormone-like glycoproteins. It is produced by numerous cell types including immune and endothelial cells. G-CSF binding to its receptor G-CSF-R which belongs to the cytokine receptor type I family depends on the interaction of alpha-helical motifs of the former and two fibronectin type III as well as an immunoglobulin-like domain of the latter. Recent animal studies have also revealed that G-CSF activates multiple signaling pathways, such as Akt and also the Janus family kinase-2 and signal transducer and activation of transcription-3 (Jak2-STAT3) pathway, thereby promoting survival, proliferation, differentiation and mobilisation of haematopoietic stem and progenitor cells. G-CSF is a cytokine that have been demonstrated to improve cardiac function and perfusion in myocardial infarction. And it was initially evaluated as a stem cell mobilizer and erythropoietin as a cytoprotective agent. G-CSF prevents left ventricular remodeling after myocardial infarction by decreasing cardiomyocyte death and by increasing the number of blood vessels, suggesting the importance of direct actions of G-CSF on the myocardium rather than through mobilization and differentiation of stem cells. Accordingly, recombinant human (rh)G-CSF has been extensively used in clinical haematology and oncology to enable bone marrow transplantation or to treat chemotherapy-associated neutropenia. In preclinical study, G-CSF improved cardiac function and perfusion by angiomyogenesis and protection of cardiomyocytes in myocardial infarction. |
Fig.Mouse G-CSF protein
(空格分隔,最多3個,單個標(biāo)簽最多10個字符)